NCT00063219 2009-08-21
Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 2 Completed
Wyeth is now a wholly owned subsidiary of Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer
Taxolog Inc.